These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18752508)

  • 1. In search of improved prostaglandin treatment for glaucoma.
    Thygesen J
    Acta Ophthalmol Suppl (Oxf ); 2008; 242():5-6. PubMed ID: 18752508
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of prostaglandin analogues in the treatment of glaucoma in the 21st century.
    Nguyen QH
    Int Ophthalmol Clin; 2004; 44(2):15-27. PubMed ID: 15087728
    [No Abstract]   [Full Text] [Related]  

  • 3. Ocular hypotensive medications for the treatment of glaucoma.
    Lee DA
    Ophthalmol Clin North Am; 2005 Dec; 18(4):529-38. PubMed ID: 16314217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroprotection and vasoprotection in glaucoma].
    Ignat F
    Oftalmologia; 2004; 48(2):5-14. PubMed ID: 15341092
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glaucoma--strategy of treatment].
    Stefan C; Selaru D; Stefaniu I; Dumitrică DM
    Oftalmologia; 2008; 52(3):3-6. PubMed ID: 19149110
    [No Abstract]   [Full Text] [Related]  

  • 6. [Approaches to reduction of intraocular pressure by 30% in patients with glaucoma (review of literature)].
    Kuroedov AV; Brezhnev AIu; Aleksandrov AS
    Voen Med Zh; 2009 Jun; 330(6):40-6. PubMed ID: 19791687
    [No Abstract]   [Full Text] [Related]  

  • 7. Spanish multicenter tafluprost tolerability study.
    Milla E; Stirbu O; Rey A; Duch S; Buchacra O; Robles A; Navarro C; Gil R; Cordero JM
    Br J Ophthalmol; 2012 Jun; 96(6):826-31. PubMed ID: 22399693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [For 150 years it is possible to treat glaucoma with intraocular pressure reducing drugs].
    Erb C
    Klin Monbl Augenheilkd; 2013 Feb; 230(2):113. PubMed ID: 23430675
    [No Abstract]   [Full Text] [Related]  

  • 9. How I choose a prostaglandin analogue.
    Alward WL
    Am J Ophthalmol; 2009 Jan; 147(1):1-2. PubMed ID: 19100349
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical management of glaucoma.
    Geringer CC; Imami NR
    Int Ophthalmol Clin; 2008; 48(4):115-41. PubMed ID: 18936640
    [No Abstract]   [Full Text] [Related]  

  • 11. Glaucoma. Eye series. 7.
    Hodge C; Roberts T
    Aust Fam Physician; 2003 Aug; 32(8):643-4. PubMed ID: 12973875
    [No Abstract]   [Full Text] [Related]  

  • 12. Bimatoprost: establishing its role in glaucoma management.
    Katz LJ
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S1-4. PubMed ID: 15016555
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessing the effectiveness of medical treatment for glaucoma.
    Thomas R; Mengersen K
    Clin Exp Ophthalmol; 2011 Dec; 39(9):919-21. PubMed ID: 21631681
    [No Abstract]   [Full Text] [Related]  

  • 14. 24-h Intraocular pressure control with evening-dosed travoprost/timolol, compared with latanoprost/timolol, fixed combinations in exfoliative glaucoma.
    Konstas AG; Mikropoulos DG; Embeslidis TA; Dimopoulos AT; Papanastasiou A; Haidich AB; Stewart WC
    Eye (Lond); 2010 Oct; 24(10):1606-13. PubMed ID: 20651749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glaucoma therapy: "above all do no harm".
    Sekhar GC
    Indian J Ophthalmol; 2001 Jun; 49(2):79-80. PubMed ID: 15884510
    [No Abstract]   [Full Text] [Related]  

  • 16. Tafluprost for glaucoma.
    Papadia M; Bagnis A; Scotto R; Traverso CE
    Expert Opin Pharmacother; 2011 Oct; 12(15):2393-401. PubMed ID: 21916788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
    Nazm N; Dubey S; Gandhi M; Pegu J
    Am J Ophthalmol; 2010 Mar; 149(3):525-6; author reply 526-7. PubMed ID: 20172078
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy and tolerability of preservative-free tafluprost 0.0015 % in the treatment of glaucoma and ocular hypertension].
    Karhanová M; Mlčák P; Fryšák Z; Marešová K
    Cesk Slov Oftalmol; 2012 Oct; 68(4):150-5. PubMed ID: 23214487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized clinical trial of the efficacy and safety of preservative-free tafluprost and timolol in patients with open-angle glaucoma or ocular hypertension.
    Chabi A; Varma R; Tsai JC; Lupinacci R; Pigeon J; Baranak C; Noble L; Lines C; Ho TW
    Am J Ophthalmol; 2012 Jun; 153(6):1187-96. PubMed ID: 22310086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative analysis of life quality in patients receiving beta-blockers and xalathane (latanoprost)].
    Tugushi OA; Shliapuzhnikova AV; Listopadova NA
    Vestn Oftalmol; 2005; 121(4):41-3. PubMed ID: 16223045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.